These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29764056)

  • 1. Nonstandard personalized medicine strategies for cancer may lead to improved patient outcomes.
    Beckman RA; Yeang CH
    Per Med; 2014 Sep; 11(7):705-719. PubMed ID: 29764056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
    Beckman RA; Schemmann GS; Yeang CH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
    Yeang CH; Beckman RA
    Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
    Verma M
    Per Med; 2014 Nov; 11(8):761-771. PubMed ID: 29764045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized health care: from theory to practice.
    Snyderman R
    Biotechnol J; 2012 Aug; 7(8):973-9. PubMed ID: 22180345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing breast cancer treatment-The dawn of personalized medicine.
    Nandy A; Gangopadhyay S; Mukhopadhyay A
    Exp Cell Res; 2014 Jan; 320(1):1-11. PubMed ID: 24051330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamics: New Frontier in Personalized Medicine.
    Sneha P; Doss CG
    Adv Protein Chem Struct Biol; 2016; 102():181-224. PubMed ID: 26827606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity.
    Heath A; Pechlivanoglou P
    Med Decis Making; 2022 Jul; 42(5):649-660. PubMed ID: 35023403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging science and therapies in non-small-cell lung cancer: targeting the MET pathway.
    Kris MG; Arenberg DA; Herbst RS; Riely GJ
    Clin Lung Cancer; 2014 Nov; 15(6):475. PubMed ID: 25306384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-based and diagnostics-linked personalized medicine for cancer.
    Srivastava S; Wagner PD
    Per Med; 2007 Feb; 4(1):33-43. PubMed ID: 29793301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
    Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric Cancer in the Era of Precision Medicine.
    Liu X; Meltzer SJ
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):348-358. PubMed ID: 28462377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine: individualized care of cancer patients.
    Ely S
    Transl Res; 2009 Dec; 154(6):303-8. PubMed ID: 19931196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics-based nanomedicine: the future of personalized oncology.
    Rosenblum D; Peer D
    Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.